ACADIA PHARMACEUTICALS INC - Common Stock (ACAD)

CUSIP: 004225108

Q3 2021 13F Holders as of 30 Sep 2021

Holder snapshot 7 signals
Share change
-2,320,453
Put/Call ratio
36%
SEC-reported price per share
$16.61
Number of holders
221
Value change
-$85,712,883
Number of buys
97
Open additional details 1 more signal available
Number of sells
114
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
170,504,990

Security key

004225108

Report period

Q3 2021

Institutions

221

Top holders

10

Ownership snapshot

Top reported holders of ACAD - ACADIA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
15/15
Latest evidence
30 Jun 2021
13F Lead comparable stake: 25% Showing 1-6 of 15 holder rows.

Quick read

BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 25%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAKER BROS. ADVISORS LP's linked filing trail.
Comparable ownership Top 5
BAKER BROS. ADVISORS LP 25%
FMR LLC 9.1%
VANGUARD GROUP INC 6.8%
PRICE T ROWE ASSOCIATES INC /MD/ 6%
BlackRock Finance, Inc. 5.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BAKER BROS. ADVISORS LP
13F
Company
13F
25%
$1,022,202,000
41,910,704 shares
30 Jun 2021
FMR LLC
13F
Company
13F
9.1%
$378,024,000
15,499,138 shares
30 Jun 2021
VANGUARD GROUP INC
13F
Company
13F
6.8%
$280,932,000
11,518,317 shares
30 Jun 2021
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
6%
$248,749,000
10,198,831 shares
30 Jun 2021
BlackRock Finance, Inc.
13F
Company
13F
5.9%
$247,295,000
10,139,203 shares
30 Jun 2021
D. E. Shaw & Co., Inc.
13F
Company
13F
2.8%
$116,220,000
4,765,065 shares
30 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
221
Shares
144,785,492
Rows available
221
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
238
Q3 2021 holders
221
Holder diff
-17
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 value Q3 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .